findmyKOL
Clinical trialNCT03433833WithdrawnPhase 1Interventional

Digoxin for Congenital Erythrocytosis Due to Up-Regulated Hypoxia Sensing

SponsorUniversity of Illinois at ChicagoEnrollment0Chuvash ErythrocytosisErythrocytosis; FamilialHIF-2alpha ErythrocytosisPHD2 ErythrocytosisPolycythemia; FamilialVHL Gene Mutation
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
10 Nov 2019
Primary completion
16 Apr 2024
Completion
31 Dec 2024
Last update posted
20 Sept 2024
Registered enrollment
0
Registry id
NCT03433833

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.